The Food and Drug Administration Aug. 1 said U.S. consumers should not use emergency birth control medicines labeled as Evital.
These products may be counterfeit versions of the “morning- after pill” and may not be safe or effective in preventing pregnancy, the agency said. FDA has not approved Evital for use in the United States.
FDA said this potentially ineffective and suspect counterfeit emergency birth control also may be in distribution in some Hispanic communities in the United States. The packaging label of the potentially ineffective and suspect counterfeit version says, “Evital Anticonceptivo de emergencia, 1.5 mg [milligram], 1 tablet,” ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.